Nachrichten zur Pfizer Inc. Aktie

These 7 Blunt Words Just Opened a Can of Worms For Pfizers Stock @themotleyfool #stocks $PFE

The companys problems are no longer deniable.…

Motley Fool: Dividends can pile up for patient Pfizer investors

Pfizer faces challenges after demand for the COVID vaccine waned, but it has planned for this moment and is finishing…

Pfizer’s Activist Battle Might Fizzle—but Its Stock Probably Won’t

…

Kurs der Pfizer-Aktie verharrt auf Vortags-Niveau (26,3467 €)

Der Kurs der der Pfizer-Aktie kommt kaum von der Stelle. Der jüngste Kurs betrug 28,46 US-Dollar. Einen geringen Wertverlust von…

Pfizer Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 30…

JPMORGAN stuft PFIZER INC auf Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 30…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 30…

A Pfight At Pfizer

…

Pfizer Q3 Preview: Why The Stock Is A Buy Ahead Of Earnings

…

The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron and Biogen

Novo Nordisk, Novartis, Pfizer, Regeneron and Biogen are included in this Analyst Blog.…

Biotech mit Überraschungspotenzial - Bayer, BioNTech, CureVac, Medigene, Pfizer Aktie

Die hohe Volatilität im Biotech-Sektor zieht einige Investoren magisch an, während andere Investoren diesen Spezialmarkt lieber meiden. Doch wenn die…

The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and Biogen

Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and Biogen are included in this Analyst Blog.…

FDA approves Pfizers RSV vaccine for adults at increased risk of the disease

The U.S. Food and Drug Administration on Tuesday approved Pfizers RSV vaccine for the prevention of lower respiratory tract disease caused by…

Starboard Value CEO Jeff Smith: Pfizer needs to do a better job disciplining itself on investments

Jeff Smith, Starboard Value CEO, joins CNBCs Squawk on the Street to discuss how he sees Pfizer going forward, potential…

Starboard Value CEO says Pfizers board should hold management accountable By Reuters

Starboard Value CEO says Pfizers board should hold management accountable…

Is Pfizers Attractive Valuation Enough to Invest in the Stock?

PFEs non-COVID drugs and potential contributions from new and newly acquired products have started to drive growth.…

The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi

Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi are included in this Analyst Blog.…

Pfizer: Activists Clouding A Promising Picture

…

Pfizer Aktie: Portfolio-Neugestaltung entscheidend für zukünftiges Wachstum - Ersteinschätzung

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Sanford C. Bernstein & Co: Aktuelle Bewertung Bernstein-Analystin, Courtney Breen, hat die Coverage von Pfizer Inc.…

Pharma Stock Roundup: JNJs Q3 Earnings, FDA Nod to Some New Drugs

J&J tops third-quarter earnings and sales estimates. FDA approves new drugs of Pfizer, Roche and AbbVie.…

Why Im Considering Leaning Heavily Into Pfizer

Pfizers high dividend yield and robust pipeline could offer significant returns for patient investors.…

Why Im Considering Leaning Heavily Into Pfizer @themotleyfool #stocks $PFE

Pfizers high dividend yield and robust pipeline could offer significant returns for patient investors.…

Why Im Considering Leaning Heavily Into Pfizer

…

Pfizer taps Vanguard veteran for board amid fight with Starboard By Reuters

Pfizer taps Vanguard veteran for board amid fight with Starboard…

Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock? @themotleyfool #stocks $PFE

This investors campaign is stoking some undesirable corporate intrigue.…

Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?

This investors campaign is stoking some undesirable corporate intrigue.…

Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?

These two stocks will appeal to very different types of investors at the moment.…

Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly? @themotleyfool #stocks $PFE $LLY

These two stocks will appeal to very different types of investors at the moment.…

wO Börsenlounge - die Woche: Einstiege, Übernahmen, ein "Robotaxi-Event" und der Einbruch der China-Aktien

Neben dem Start in die Berichtssaison scheint auch das Übernahmekarussell wieder in Fahrt zu kommen. Bei Pfizer ist ein Hedgefonds…

An Activist Investor Just Bought $1 Billion Worth of Pfizer. Heres What It Means for the Stock

There may be changes coming to this company, if the activists get their way.…

An Activist Investor Just Bought $1 Billion Worth of Pfizer. Heres What It Means for the Stock @themotleyfool #stocks $PFE

There may be changes coming to this company, if the activists get their way.…

Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis

…

Pfizer Aktie: Kursrutsch trotz positiver Studienergebnisse

Die Pfizer-Aktie verzeichnete am Montag deutliche Verluste an der New Yorker Börse. Der Kurs fiel um 2,1 Prozent auf 29,57…

Will Pfizer transform in response to Starboard’s activism?

…

Whats Going On With Pfizer Stock On Thursday?

…

Pfizer threatened to sue renegade executives prior to activist schism, Starboards Smith says

Starboards Jeff Smith called on the company to assemble a special committee to investigate the matter, describing it as "flagrantly…

Starboard seeks probe after former Pfizer execs pull support for its campaign By Reuters

Starboard seeks probe after former Pfizer execs pull support for its campaign…

Pfizers CEO gains support of ex-execs amid activist investor talks

…

Pfizer Aktie: Aktivistischer Investor fordert Veränderungen

Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Pfizer: Startschuss zur Trendwende?

Knapp 3,5 Prozent hat die Aktie des Pharma-Riesen Pfizer am Mittwoch an den US-Börsen zulegen können. Für die relativ hohe…

Pfizer: Startschuss zur Trendwende?

Knapp 3,5 Prozent hat die Aktie des Pharma-Riesen Pfizer am Mittwoch an den US-Börsen zulegen können. Für die relativ hohe…

Former Pfizer CEO, CFO step back from Starboard activist bid By Investing.com

Former Pfizer CEO, CFO step back from Starboard activist bid…

Former Pfizer executives not involved in Starboards campaign against drugmaker By Reuters

Former Pfizer executives not involved in Starboards campaign against drugmaker…

Former Pfizer CEO, CFO say they will not be involved in Starboards campaign against drugmaker

…

Former Pfizer CEO, finance chief step back from Starboards activist campaign

The about face comes as the board grapples with the activists efforts, and just days before Starboards Jeff Smith was…

Statement From Former Pfizer CEO Ian Read and Former Pfizer CFO Frank D’Amelio Regarding Starboard Value

NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Guggenheim Securities, LLC is issuing a statement on behalf of…

Why Pfizer Stock Popped Today

…

Why Pfizer Stock Popped Today

The sharp, sudden entry of an activist investor is raising hopes that change might come to the company.…

GSK, Pfizer seeing drop in demand for RSV vaccines: report

…

Pfizer gains as CEO said to meet activist Starboard By Investing.com

Pfizer gains as CEO said to meet activist Starboard…